Safety assessment of a novel C-type natriuretic peptide derivative and the mechanism of bone- and cartilage-specific toxicity

ASB20123, a C-type natriuretic peptide/ghrelin chimeric peptide, was designed as a novel peptide and demonstrated full agonistic activity for natriuretic-peptide receptor B and a significantly longer half-life in plasma compared with the native peptide. We researched the toxicological profile of ASB...

Descripción completa

Detalles Bibliográficos
Autores principales: Yotsumoto, Takafumi, Morozumi, Naomi, Nakamura, Ryuichi, Jindo, Toshimasa, Furuya, Mayumi, Abe, Yasuyuki, Nishimura, Tomonari, Maeda, Hiroaki, Ogasawara, Hiroyuki, Minamitake, Yoshiharu, Kangawa, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738601/
https://www.ncbi.nlm.nih.gov/pubmed/31509532
http://dx.doi.org/10.1371/journal.pone.0218229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738601/
https://www.ncbi.nlm.nih.gov/pubmed/31509532
http://dx.doi.org/10.1371/journal.pone.0218229

Ejemplares similares